NIH funds Kirschstein Award recipient Johan Girgenrath’s fertility research
PhD candidate John Girgenrath has received a competitive award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to conduct fertility research.
Read more
, Graduate School of Biomedical Sciences, Student, Craig C. Mello, Award, Research, Interdisciplinary, RNA Therapeutics Institute, Program in Molecular Medicine, Latest News, Mello Lab, Top Stories,
Biomedical sciences student studying fertility in Mello lab
Movies piqued PhD candidate Humberto Ochoa’s interest in science. He’s conducting RNA research in the lab of Nobel Laureate Craig C. Mello, PhD, to understand the national decline in fertility.
Read more
, Graduate School of Biomedical Sciences, Faculty, Student, Craig C. Mello, Interdisciplinary, RNA Therapeutics Institute, Student Spotlight, Latest News, Mello Lab,
Biomedical sciences student works toward a future in genetic engineering
PhD student Katya Makeyeva investigates how small RNA pathways regulate gene expression of reproductive cells in the lab of Nobel Laureate Craig Mello, PhD.
Read more
, Graduate School of Biomedical Sciences, Faculty, Student, Craig C. Mello, RNA Therapeutics Institute, Student Spotlight, Latest News, Mello Lab,
Atalanta Therapeutics founded by UMass Medical School and three faculty members
Atalanta Therapeutics, a biotech founded by UMass Medical School and three faculty research scientists to pioneer treatment options for neurodegenerative diseases, has launched with financing by venture capital fund F-Prime Capital and strategic collaborations with Biogen and Genentech.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Medicine, Clinician, Faculty, Craig C. Mello, Anastasia Khvorova, RNA Therapeutics Institute, Aronin Lab, Program in Molecular Medicine, Neil Aronin,
Inside the new mRNA vaccines for COVID-19
The new vaccines by Pfizer/BioNTech and Moderna use messenger RNA to stimulate the immune system to protect against COVID-19. These vaccines are the first of their kind and researchers at UMass Medical School are among the leading RNA biologists in the world.
Read more
, Graduate School of Biomedical Sciences, School of Medicine, Office of Advancement, Faculty, Craig C. Mello, Anastasia Khvorova, Jonathan K. Watts, Novel Coronavirus, Biochemistry and Molecular Biotechnology, RNA Therapeutics Institute, Ambros Lab, Phillip Zamore, Program in Molecular Medicine,
